HM PharmaConsultancy
@hmpharmacon
Followers
486
Following
99
Media
26
Statuses
2K
H.M. Pharma Consultancy - The Life Science Knowledge Foundry - advises on drug development, repurposing, and patenting. Mastodon: @[email protected]
Austria
Joined January 2010
How AI can help find new uses for the drugs we have
icthealth.org
Prof. Harald Schmidt explains how artificial intelligence could unleash a revolution in reusing existing drugs to treat diseases once thought untreatable.
0
0
1
Hermann Mucke will present "RepoScope: An AI-supported database to build a navigable network of drug repurposing prior art" at #RExPO25. A first for a broad audience! -
drugrepocentral.scienceopen.com
Drug repurposing projects require comprehensive evaluation of relevant prior research before formalization. While peer-reviewed literature searching is fundamental in life sciences education, patent...
0
0
1
New journal at #ScienceOpen: Network and Systems Medicine https://t.co/wVJcr6y7t5 The first papers: https://t.co/fPorHWodrx) and
drugrepocentral.scienceopen.com
Network medicine relies on RNA sequencing to infer gene co-expression networks, which are crucial to identify functional gene clusters and gene regulatory interactions, and offer a deeper understan...
0
1
3
'International Drug Repurposing Patent Landscape, Part 3: Chronic Neurodegenerative Diseases 2010-2024' an article on #ScienceOpen:
0
0
0
International Drug Repurposing Patent Landscape, Part 3: Chronic Neurodegenerative Diseases 2010-2024 DrugRxiv DOI:
drugrepocentral.scienceopen.com
This study presents a comprehensive landscape of international drug repurposing patent applications published between January 2010 and December 2024, encompassing four chronic neurodegenerative...
0
0
0
🎄With our Christmas Newsletter🌟, we wish you a wonderful holiday season & a happy + healthy new year: https://t.co/0eEcO1RdbK See you again in 2025😊 #ProposalWriting #ScienceCommunication #ProjectManagement #ConferenceServices
@HorizonEU @ERC_Research @BMBF_Bund @dfg_public
0
5
7
What we love about our General Assemblies: We get to receive quality #feedback, from our Scientific and Ethical Advisory Board Members Dr. #HermannMucke of @hmpharmacon, also on behalf of Prof. #DominiqueValla,
0
5
9
'International Drug Repurposing Patent Landscaping, Part 2: The Early Months of Covid-19' an article on #ScienceOpen:
0
0
1
Patent highlights February–March 2024
tandfonline.com
A snapshot of noteworthy recent developments in the patent literature of relevance to pharmaceutical and medical research and development.
0
0
0
Next up: Work package presentations! 🧪 Selection and validation of combinatorial therapies using #preclinical rat models and set-up of #biomarkers of outcome and of companion diagnostics in patients’ samples. Presented by @UschnerFrank
#ACLF @MEDB_LAB @JonelTrebicka
1
5
10
The value of ‘wasting time’ on deep thinking is often overlooked in a scientific ecosystem increasingly tainted by Wall Street’s productivity mindset. https://t.co/hNTA74DNOr
45
2K
5K
In the inaugural issue of the new #ScienceOpen OA journal, #DrugRepurposing: #Patent Landscaping for #rarediseases 2010–2023 https://t.co/lqciO5EHKz
drugrepocentral.scienceopen.com
In this first installment of a series of papers on landscaping of drug repurposing patents, we present an analysis in the context of rare diseases. Using the RepoScope drug repurposing database,...
0
0
0
⭐️New Editor Spotlight on Hermann Mucke⭐️ Founder and CEO of @hmpharmacon, and a pivotal contributor to @REPO4EU, Mucke is a pioneer in #DrugRepurposing. Read more in our latest blog-post 👇 https://t.co/F71ab3saMs
0
3
5
@SDawsonBerlin @hhhwschmidt 💊 'Drug Repurposing: Then, Now, and in the Future' is an Honorary Lecture by Hermann Mucke of @hmpharmacon from Systems Medicine, AI, and Drug Repurposing (RExPO23), detailing the history and future potential of drug repurposing.
drugrepocentral.scienceopen.com
Contrary to the definition of a drug, drug repurposing usually involves the redevelopment of an active pharmaceutical ingredient (API) for a substantially different medical use; only rarely is this...
0
2
1
Just finished the final review with the EU Commission's #HADEA for our concluded #H2020 #drugrepurposing project, REPO-TRIAL ( https://t.co/GVluRPdIus). We have already made a smooth transition to the much larger #HorizonEurope follow-up project, #REPO4EU ( https://t.co/yrAQwOOPJr)
0
0
1
One for the tractable proteome aficionados. Selects from the human Swiss-Prot cross-refs for chemistry (except Pharos under Miscellaneous) Interesting but also slightly puzzling aspects (e.g. 47 Tchem not in ChEMBL) Note 132 BindingDB uniques may include patent-only targets
0
1
0
#DrugRepurposing: Then, Now, and in the Future - from the REXPO23 conference
drugrepocentral.scienceopen.com
Contrary to the definition of a drug, drug repurposing usually involves the redevelopment of an active pharmaceutical ingredient (API) for a substantially different medical use; only rarely is this...
0
1
0
Patent Highlights April–May 2023 | Pharmaceutical Patent Analyst
0
0
0